spacer
home > ebr > summer 2003 > giving vaccines the boost they need
PUBLICATIONS
European Biopharmaceutical Review

Giving Vaccines the Boost They Need

Estimated revenues for therapeutic biologics are set to grow to $50 billion per annum, with immunotherapeutics predicted to grow to 10 per cent of the prescription drug market ($40 billion) within the next decade. Creating immunotherapeutics for diseases such as cancer however, represents a significant challenge for the industry. For example cancer vaccines have to overcome 'self tolerance', the immune system's in-built reluctance to attack its own cells.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Deirdre Gillespie, President and Chief Executive Officer at Oxxon PharmaccinesTM Ltd

Dr Deirdre Gillespie is President and Chief Executive Officer of Oxxon PharmaccinesTM Ltd, a biotechnology company developing innovative immunotherapeutics, specifically therapeutic vaccines (pharmaccines), for the treatment of chronic infectious diseases and cancer. While at Oxxon, Deirdre has overseen the progression of the company's pharmaccines for the treatment of Hepatitis B and malignant melanoma into Phase II clinical trials.

Deirdre was also instrumental in a recently announced private financing that saw Oxxon raise £15 million in an international funding round. She has 16 years' experience in the pharmaceutical and biotechnology industries including senior positions at Vical Inc and DuPont Merck Pharmaceutical Company. Deirdre gained a medical degree from London University and an MBA from London Business School.

spacer
Dr Deirdre Gillespie
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PCI Pharma Services Announces Organization Updates

Philadelphia, PA – May 20, 2019 – PCI Pharma Services, a leading biopharmaceutical outsourcing services provider, is pleased to announce the following management updates to help drive the company’s future vision, strategy and growth.
More info >>

White Papers

The Rare Disease Patients Experience

When planning a clinical trial for a rare disease, it is important to have a holistic understanding of your patient population. You want to be aware of where your patients are coming from, and what it is like to walk in their shoes. These patients need your trial just as much as you need them; even from the earliest stages, conceptualize your rare disease trial as an altruistic relationship between the patient population and your study.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement